Zacks Investment ResearchThu, 04 Jun 2026 17:01:16 GMTKalVista Pharmaceuticals (KALV) Upgraded to Buy: What Does It Mean for the Stock?KALV+0.02%
Seeking AlphaTue, 07 Apr 2026 10:11:43 GMTKalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case AliveKALV+0.02%
Seeking AlphaWed, 25 Mar 2026 18:55:54 GMTKalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call TranscriptKALV+0.02%